Cenobamate Restart After a Hospital Break: What a Small Study Found

What was studied

Researchers looked at what happened when people with epilepsy stopped cenobamate for a short time during a hospital stay for intracranial EEG testing, then restarted it at maintenance doses rather than slowly increasing it again.

This was a retrospective study at one tertiary epilepsy center. It included 32 patients who were already taking cenobamate when they were admitted. The median age was 29 years, 53% were female, cenobamate was withheld for a median of 7 days, and patients were followed during the hospital stay and for 2 weeks after discharge.

What they found

No hypersensitivity reactions attributable to cenobamate were observed after restarting the drug, including no rash attributable to cenobamate, during hospitalization or follow-up. Patients restarted at a median dose of 200 mg/day, and 25% restarted at 300 mg/day or higher. This included patients with a history of rash and four patients whose interruption lasted 10 days or more. The authors describe this as first evidence that short-term cenobamate interruptions may not require retitration in patients who had previously tolerated the medicine.

Limits of the evidence

This study was small, with only 32 patients, and it was done at a single center. It was retrospective, meaning the researchers looked back at medical records rather than testing a planned treatment approach. The follow-up was short, only through hospitalization and 2 weeks after discharge. Most interruptions were about a week, so the study does not show what happens after longer gaps. It also cannot show that restarting at maintenance doses is safe in all situations; it only reports that no attributable reactions were observed in this group.

For families and caregivers

This is early evidence from a small, closely monitored hospital group, not a tested rule for restarting cenobamate at home. The absence of an attributed reaction in 32 people does not rule out rare or serious reactions. If treatment has been interrupted, contact the prescriber for an individualized restart plan; do not use the study’s doses or interruption lengths as instructions.

What to watch next

Larger prospective studies are needed to assess safety in more patients, with longer interruptions and longer follow-up after restarting cenobamate.

Terms in this summary

cenobamate

A seizure medicine used to treat some types of epilepsy.

hypersensitivity reaction

An unwanted reaction to a medicine, such as rash or other allergy-like symptoms.

retitration

Restarting a medicine slowly by increasing the dose step by step.

retrospective study

A study that looks back at existing medical records instead of assigning treatment ahead of time.

intracranial EEG

A test that records brain activity using electrodes placed inside the skull to help evaluate seizures.

tertiary epilepsy center

A specialized hospital center that treats complex epilepsy cases.